$5.95
-0.300 (-4.80%)
At Close: Jul 13, 2026
Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
07:30am, Monday, 09'th Nov 2020
Results from all cohorts of PRECISION-HD1 and PRECISION-HD2 clinical trials and initial OLE data on track for 1Q 2021
Sign In
Buy WVE